Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Palisade Bio (NASDAQ:PALI).
Bio-Path Hldgs has a consensus price target of $23.00.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $0.945 last updated November 14, 2024 at 3:02 PM EST.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q3 earnings are confirmed for Friday, November 15, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.